Welcome to BioReagent Hub Hotline:19920083827
Article Detail

Compliance Perspectives of Fetal Bovine Serum Virus Testing in the Biopharmaceutical Supply Chain

Industry News AI Generated
2026-09-22 09:46 Author:ABIOP Source:AI 生成 Views 159
Back to List
Compliance Perspectives of Fetal Bovine Serum Virus Testing in the Biopharmaceutical Supply Chain

Biopharma's focus on serum safety management

Fetal bovine serum is often used for cell line library building, viral vector production, vaccine research and development, and some in vitro diagnostic reagent processes.Its animal origin attributes determine that viral contamination may enter the production system through raw materials and affect the safety and batch-to-batch consistency of the final product.Therefore, biopharmaceutical companies and diagnostic reagent manufacturers often include fetal bovine serum virus testing as a key link in supplier access and material release.

General understanding of regulatory frameworks and testing requirements

Pharmacopoeia or regulatory guidelines in different countries and regions have principled requirements for fetal bovine serovirus testing items, methods, and limits.Common detection ranges include bovine-derived viruses, porcine-derived viruses, and viruses that may have been introduced during the culture process.Since regulatory documents are updated, companies should not rely only on a single certificate, but should establish a dynamic regulatory tracking mechanism in conjunction with the applicable market for the product.

At the detection method level, validated nucleic acid detection, cell culture, or immunological methods are generally required, and sample representativeness, sample storage conditions, and detection limits are reasonably described.For high-risk projects, companies may consider adding orthogonal method review to reduce the possibility of missed detection.

Supply Chain Audit and Document Traceability

The fetal bovine serum supply chain usually involves multiple links such as raw material collection, mixing, filtration, and packaging. Any omissions in any link may affect the representativeness of virus detection results.When selecting a supplier, the user should review, in addition to the test report, the following aspects:

Raw material source area and animal health

Comments2

Sign in to comment on this article

G
Gene2026-09-14 16:13

有没有同行遇到过血清病毒检测报告和实际批次对不上的情况?审计时怎么追责?

A
Amy2026-09-17 20:21

我们最近审计供应商时就盯着病毒检测报告和COA,少一项都不敢放行,合规太关键了。

✉Email 💬Message 👤Member
↑Top